These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26412148)

  • 21. Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication.
    Kim DK; Baek JH; Kang CM; Yoo MA; Sung JW; Chung HY; Kim ND; Choi YH; Lee SH; Kim KW
    Int J Cancer; 2000 Sep; 87(5):629-36. PubMed ID: 10925354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells.
    Hsu YL; Kuo PL; Lin CC
    Life Sci; 2004 Sep; 75(19):2303-16. PubMed ID: 15350828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition.
    Bi X; Xia X; Mou T; Jiang B; Fan D; Wang P; Liu Y; Hou Y; Zhao Y
    Eur J Pharmacol; 2014 Nov; 742():145-52. PubMed ID: 25199964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin.
    Navarro-Carrasco E; Campos-Díaz A; Monte-Serrano E; Rolfs F; de Goeij-de Haas R; Pham TV; Piersma SR; Jiménez CR; Lazo PA
    Chem Biol Interact; 2024 Mar; 391():110908. PubMed ID: 38367682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.
    Morgillo F; Sasso FC; Della Corte CM; Vitagliano D; D'Aiuto E; Troiani T; Martinelli E; De Vita F; Orditura M; De Palma R; Ciardiello F
    Clin Cancer Res; 2013 Jul; 19(13):3508-19. PubMed ID: 23695170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of bivalent cations in structural stabilities of new drug targets--vaccinia-related kinases (VRK) from molecular dynamics simulations.
    Fu T; Ren H; Zhang J; Ren P; Enyedy I; Li G
    Curr Pharm Des; 2013; 19(12):2269-81. PubMed ID: 23082977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VRK1 phosphorylates CREB and mediates CCND1 expression.
    Kang TH; Park DY; Kim W; Kim KT
    J Cell Sci; 2008 Sep; 121(Pt 18):3035-41. PubMed ID: 18713830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential inhibitor sensitivity between human kinases VRK1 and VRK2.
    Vázquez-Cedeira M; Barcia-Sanjurjo I; Sanz-García M; Barcia R; Lazo PA
    PLoS One; 2011; 6(8):e23235. PubMed ID: 21829721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
    Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
    Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
    Zhu K; Fang W; Chen Y; Lin S; Chen X
    Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
    Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
    Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G₁ arrest in cancer cells and xenograft models.
    Huang SM; Lu KT; Wang YC
    Anticancer Res; 2011 Jan; 31(1):203-8. PubMed ID: 21273599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursolic acid induces autophagy in U87MG cells via ROS-dependent endoplasmic reticulum stress.
    Shen S; Zhang Y; Zhang R; Tu X; Gong X
    Chem Biol Interact; 2014 Jul; 218():28-41. PubMed ID: 24802810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursolic acid: an anti-tumorigenic and chemopreventive activity. Minireview.
    Novotný L; Vachálková A; Biggs D
    Neoplasma; 2001; 48(4):241-6. PubMed ID: 11712672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase.
    Andersson D; Liu JJ; Nilsson A; Duan RD
    Anticancer Res; 2003; 23(4):3317-22. PubMed ID: 12926069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
    Yeh CT; Wu CH; Yen GC
    Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The chemical and biological potential of C ring modified triterpenoids.
    Siewert B; Wiemann J; Köwitsch A; Csuk R
    Eur J Med Chem; 2014 Jan; 72():84-101. PubMed ID: 24361521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid.
    Li Y; Xing D; Chen Q; Chen WR
    Int J Cancer; 2010 Jul; 127(2):462-73. PubMed ID: 19908232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells.
    Choi YH; Baek JH; Yoo MA; Chung HY; Kim ND; Kim KW
    Int J Oncol; 2000 Sep; 17(3):565-71. PubMed ID: 10938399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Logical design of an anti-cancer agent targeting the plant homeodomain in Pygopus2.
    Ali F; Yamaguchi K; Fukuoka M; Elhelaly AE; Kuwata K
    Cancer Sci; 2016 Sep; 107(9):1321-8. PubMed ID: 27324116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.